| |
Company
Roster
|
|
Total
Insiders : |
46 |
|
|
|
Total
Direct Shares :
|
10,376,932 |
|
|
Total
Indirect Shares :
|
19,421,160 |
| |
%
Held by Insiders:
|
7.36% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Dubois-Stringfellow Nathalie |
|
2024-02-25 |
846,188 |
|
0 |
| Pooler Amy |
|
2024-02-25 |
196,314 |
2023-11-25 |
0 |
| Macrae Sandy |
|
2024-02-25 |
2,552,204 |
2018-01-24 |
0 |
| Willoughby Scott B. |
|
2024-02-25 |
836,430 |
|
0 |
| Duraibabu Prathyusha |
|
2024-02-25 |
834,578 |
|
0 |
| Mcclung David Mark |
EVP, Chief Operating Officer |
2023-11-25 |
212,471 |
2020-06-25 |
0 |
| Fontenot Jason D. |
SVP, Chief Scientific Officer |
2023-11-25 |
136,270 |
|
0 |
| Carey Robert |
Director |
2023-06-01 |
49,600 |
2018-06-11 |
0 |
| Horn Margaret A |
Director |
2023-06-01 |
32,650 |
2022-12-15 |
0 |
| Meyers James R |
Director |
2023-06-01 |
49,600 |
2019-11-22 |
0 |
| Hillan Kenneth |
Director |
2023-06-01 |
49,600 |
2020-09-09 |
0 |
| Markels John |
Director |
2023-06-01 |
46,384 |
2020-02-11 |
0 |
| Parker H Stewart |
Director |
2023-06-01 |
62,600 |
|
0 |
| Beers Courtney |
Director |
2023-06-01 |
32,650 |
2022-12-15 |
0 |
| Smith Karen L. |
Director |
2023-06-01 |
52,100 |
2018-06-26 |
0 |
| Ramelmeier Rolf Andrew |
EVP, Technical Operations |
2023-05-25 |
171,467 |
|
0 |
| Zakrzewski Joseph S |
Director |
2022-02-25 |
60,700 |
2018-06-11 |
0 |
| Schott Robert J. |
SVP, Head of Development |
2022-02-25 |
75,537 |
2021-02-12 |
0 |
| Ramasastry Saira |
Director |
2022-02-25 |
35,700 |
2014-03-17 |
0 |
| Loeb Gary |
EVP, General Counsel & Sec. |
2021-03-23 |
83,238 |
2020-02-25 |
0 |
| Lee Sung |
EVP, Chief Financial Officer |
2020-11-25 |
88,708 |
2019-11-25 |
0 |
| Boissel Stephane |
EVP, Corp. Strategy |
2020-06-04 |
70,116 |
2019-02-25 |
0 |
| Dilly Stephen George |
Director |
2020-05-18 |
15,000 |
2018-06-11 |
0 |
| Woolfson Adrian |
EVP Research & Development |
2020-02-25 |
50,000 |
2019-01-21 |
5,001 |
| Yi Kathy |
EVP & Chief Financial Officer |
2019-05-15 |
25,512 |
2018-01-24 |
0 |
| Turner Heather D |
EVP, General Counsel & Sec. |
2019-02-25 |
19,250 |
2019-02-25 |
0 |
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
2019-01-24 |
11,291 |
2017-12-06 |
0 |
| Jeffs Roger |
Director |
2018-09-07 |
9,908 |
2018-06-11 |
0 |
| Mento Steven J |
Director |
2018-06-11 |
14,332 |
2018-06-11 |
32,214 |
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
2018-04-13 |
14,625 |
|
0 |
| Ringo William R |
Director |
2017-09-20 |
800 |
2010-04-16 |
0 |
| Lanphier Edward O Ii |
Director |
2016-12-12 |
41,663 |
2016-12-12 |
1,252,119 |
| Nichol Geoffrey |
Executive Vice President, R&D |
2015-12-12 |
159,676 |
2011-12-08 |
0 |
| Wolff Henry Ward |
Exec VP & CFO |
2015-12-12 |
206,829 |
|
0 |
| Ando Dale G |
VP, Therapeutic Dev. & CMO |
2015-12-12 |
107,328 |
2011-12-08 |
0 |
| Gregory Philip D |
SVP of Research & CSO |
2015-06-01 |
116,410 |
|
0 |
| Larson John William |
Director |
2015-01-05 |
214,660 |
2008-07-31 |
116,260 |
| Kolchinsky Peter |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
| Cleveland Paul B |
Director |
2014-01-15 |
0 |
2010-12-22 |
0 |
| Ichikawa David G |
Senior VP, Bus. Dev. |
2011-12-08 |
25,000 |
2008-01-15 |
0 |
| Zante Greg |
VP, Finance & Administration |
2008-02-14 |
693 |
2004-09-29 |
0 |
| Gerber William G |
Director |
2007-12-06 |
68,300 |
2007-09-24 |
74,400 |
| Kopp Leroy C |
10% Owner |
2007-07-06 |
735,000 |
2007-07-06 |
277,000 |
| Bluford Peter |
VP, Corporate Development |
2004-09-27 |
135,791 |
2004-09-27 |
1,200 |
| Jacoby Jon E M |
Director |
2004-02-11 |
333 |
2004-02-11 |
10,500 |
| Biogen Ma Inc. |
10% Owner |
|
0 |
2023-09-26 |
17,652,466 |
|
0.04 (6.83%) 
